Why Do We Produce Anti-Gal
Author:
- Uri GaliliUGUri Galili
- 1 January 2018
- book chapter
- Published by Elsevier
- p. 23-43
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Intestinal microbiota in human health and disease: the impact of probioticsGenes & Nutrition, 2011
- Ruminant diets and the Miocene extinction of European great apesProceedings Of The Royal Society B-Biological Sciences, 2010
- Uniquely human evolution of sialic acid genetics and biologyProceedings of the National Academy of Sciences, 2010
- Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing α-gal epitopesVaccine, 2010
- The αGal Epitope of the Histo-Blood Group Antigen Family Is a Ligand for Bovine Norovirus Newbury2 Expected to Prevent Cross-Species TransmissionPLOS Pathogens, 2009
- Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for diseaseGlycobiology, 2008
- Immunogenicity of Influenza Virus Vaccine Is Increased by Anti-Gal-Mediated Targeting to Antigen-Presenting CellsJournal of Virology, 2007
- Identification of a rare blood group, "Bombay (Oh) phenotype," in Bhuyan tribe of Northwestern Orissa, IndiaIndian Journal of Human Genetics, 2007
- Increased Immunogenicity of Human Immunodeficiency Virus gp120 Engineered To Express Galα1-3Galβ1-4GlcNAc-R EpitopesJournal of Virology, 2006
- Antigen of “serum sickness” type of heterophile antibodies in human sera: Identification as gangliosides with N-glycolylneuraminic acidBiochemical and Biophysical Research Communications, 1977